Soluble Γc Receptor Attenuates Anti-Tumor Responses of CD8+ T Cells in T Cell Immunotherapy

International Journal of Cancer - United States
doi 10.1002/ijc.31402
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

YAP Attenuates CD8 T Cell-Mediated Anti-Tumor Response

Frontiers in Immunology
AllergyImmunology
2020English

Beta-Adrenergic Signaling Impairs Anti-Tumor CD8+ T Cell Responses to B Cell Lymphoma Immunotherapy

Cancer immunology research
Cancer ResearchImmunology
2017English

Enhanced Local and Systemic Anti-Melanoma CD8+ T Cell Responses After Memory T Cell-Based Adoptive Immunotherapy in Mice

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2016English

Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-Tumor T Cell Responses

Immunity
Infectious DiseasesAllergyImmunology
2015English

Measuring CD8+ T Cell Tumor Infiltration to Guide Immunotherapy Selection

Science-Business eXchange
2013English

CD4+T Cells Are Able to Promote Tumor Growth Through Inhibition of Tumor-Specific CD8+T-Cell Responses in Tumor-Bearing Hosts

Cancer Research
Cancer ResearchOncology
2005English

OX40 Agonist Immunotherapy Expands Tumor Reactive CD8 T Cells With a Unique T Cell Receptor Repertoire and Synergizes With PDL-1 Blockade to Promote Tumor Regression

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Amphiregulin Activates Regulatory T Lymphocytes and Suppresses CD8+ T Cell-Mediated Anti-Tumor Response in Hepatocellular Carcinoma Cells

Oncotarget
Oncology
2015English

Structural Basis for Enabling T-Cell Receptor Diversity Within Biased Virus-Specific CD8+ T-Cell Responses

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy